Evidence map›Paper›PMID 27575980›Full record

ArticleAddictive behaviors2017

Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder.

R Kathryn McHugh, Victoria R Votaw, Olivera Bogunovic, Sterling L Karakula, Margaret L Griffin, Roger D Weiss

Abstract read
In one paragraph

Article in Addictive behaviors, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Initial validation of the expectancies for Benzodiazepine Analgesia Scale.Experimental and clinical psychopharmacology · 2024
    Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

R Kathryn McHughDivision of Alcohol and Drug Abuse, McLean Hospital, United States; Department of Psychiatry, Harvard Medical School, United States. Electronic address: kmchugh@mclean.harvard.edu.
Victoria R VotawDivision of Alcohol and Drug Abuse, McLean Hospital, United States.
Olivera BogunovicDivision of Alcohol and Drug Abuse, McLean Hospital, United States; Department of Psychiatry, Harvard Medical School, United States.
Sterling L KarakulaDivision of Alcohol and Drug Abuse, McLean Hospital, United States.
Margaret L GriffinDivision of Alcohol and Drug Abuse, McLean Hospital, United States; Department of Psychiatry, Harvard Medical School, United States.
Roger D WeissDivision of Alcohol and Drug Abuse, McLean Hospital, United States; Department of Psychiatry, Harvard Medical School, United States.
Harvard University · USMcLean Hospital · US

Funding

Mentoring in Drug Abuse and Dual Diagnosis ResearchK24DA022288 · NIDA · MCLEAN HOSPITAL · PI WEISS, ROGER D. · 2007 to 2016
$1.8M
GENDER DIFFERENCES IN MECHANISMS OF RECOVERY FROM OPIOID USE DISORDER AND ANXIETYK23DA035297 · NIDA · MCLEAN HOSPITAL · PI MCHUGH, REBECCA KATHRYN · 2014 to 2018
$959k
NIDA NIH HHS K23 DA035297NIDA NIH HHS K24 DA022288
6 · The paper itself

Abstract

Nonmedical benzodiazepine use is common among adults with opioid use disorder; however, little is known about this co-occurrence. Anxiety sensitivity-the fear of anxiety symptoms and sensations-motivates behaviors to escape and avoid distressing states, and accordingly is associated with coping motives for substance use. This might be particularly relevant among women, who report using substances to cope with negative emotions more often than men. The aim of the current study was to examine whether nonmedical benzodiazepine use was associated with higher anxiety sensitivity among treatment-seeking adults diagnosed with opioid use disorder, and to investigate whether gender moderated this association. A sample of adults (ranging in age from 18 to 81years) receiving inpatient treatment for opioid use disorder (N=257) completed measures of anxiety, anxiety sensitivity, and benzodiazepine use frequency. Results of an analysis of variance indicated that frequency of past-month nonmedical benzodiazepine use was associated with significantly higher anxiety sensitivity. This effect remained when controlling for the effect of anxiety symptoms (F[1, 251]=3.91, p=0.049, η

Indexed as

BenzodiazepinesAdultAnti-Anxiety AgentsAnxiety DisordersComorbidityFemaleHumansMaleOpioid-Related DisordersPrescription Drug MisuseSex FactorsSubstance-Related DisordersAnti-Anxiety AgentsBenzodiazepinesAnxiety sensitivityBenzodiazepinesGender differencesOpioid use disorder

Identifiers

PMID27575980
PMCPMC5140702
OpenAlexW2510513160

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.